[Back to Our Trials]

QUILT 2.023: A Phase 3, Open-Label, 3-Cohort Randomized Study of N-803, in Combination With Current Standard of Care VS Standard of Care as First-Line Treatment for Patients With Advanced or Metastatic NSCLC

Condition: Non-small Cell Lung Cancer


Go To Trial Homepage


For more information you may call clinical trials department directly at 732-390-7750 or email us at astera.clinicaltrial@asterahealthcare.org.